{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:39:41Z","timestamp":1778103581731,"version":"3.51.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008441","name":"CYTED Ciencia y Tecnolog\u00eda para el Desarrollo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"DOI":"10.3389\/fpubh.2019.00275","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T12:46:49Z","timestamp":1570193209000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["Changing Trends in the Epidemiology and Risk Factors of Pneumocystis Pneumonia in Spain"],"prefix":"10.3389","volume":"7","author":[{"given":"Estefan\u00eda","family":"Pereira-D\u00edaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fidel","family":"Moreno-Verdejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"de la Horra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique J.","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Medrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3201\/eid1010.030985","article-title":"Current epidemiology of Pneumocystis pneumonia","volume":"10","author":"Morris","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/CMR.00013-12","article-title":"Colonization by Pneumocystis jirovecii and its role in disease","volume":"25","author":"Morris","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(99)03287-0","article-title":"Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection","volume":"353","author":"Weverling","year":"1999","journal-title":"EuroSIDA study group. Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1051\/parasite\/2011183219","article-title":"Pneumocystis jirovecii pneumonia in developing countries","volume":"18","author":"De Armas","year":"2011","journal-title":"Parasite"},{"key":"B6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1586\/eri.10.42","article-title":"Pneumocystis infection in humans: diagnosis and treatment","volume":"8","author":"Calder\u00f3n","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B7","unstructured":"Pneumocystis jirovecii pneumonia in AIDS patients11342\n            VarelaJM\n            MedranoFJ\n            Dei-CasE\n            CalderonEJ\n          \n            ZajacV\n          RijekaInTechMicrobes, Viruses and Parasites in AIDS Process2011"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1242.e11","DOI":"10.1016\/j.amjmed.2014.07.010","article-title":"Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients","volume":"127","author":"Fillatre","year":"2014","journal-title":"Am J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/1753465810380102","article-title":"Update on the diagnosis and treatment of Pneumocystis pneumonia","volume":"5","author":"Carmona","year":"2011","journal-title":"Ther Adv Respir Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/cid\/cir329","article-title":"Increasing frequency of Pneumocystis jirovecii pneumonia in renal transplant recipients in the United Kingdom: clonal variability, clusters, and geographic location","volume":"53","author":"Thomas","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000-2010","volume":"19","author":"Maini","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"19906","DOI":"10.7448\/IAS.18.1.19906","article-title":"Pneumocystis pneumonia in HIV-positive patients in Spain: epidemiology and environmental risk factors","volume":"18","author":"Alvaro-Meca","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"B13","unstructured":"Base 2011. A\u00f1o 2012Instituto Nacional de Estad\u00edstica de Espa\u00f1a. \u00cdndice de Precios de Consumo (IPC).2018"},{"key":"B14","unstructured":"Clinical Classifications Software (CCS) for ICD-9-CM2018"},{"key":"B15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2141.2002.03419.x","article-title":"Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years'experience of infection in GIMEMA centres","volume":"117","author":"Pagano","year":"2002","journal-title":"Br J Haematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"59729","DOI":"10.18632\/oncotarget.19927","article-title":"Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"B17","unstructured":"Manual de usuario Mi CMBD2014"},{"key":"B18","unstructured":"CMBDHospital Discharge Records in the National Health System.2018"},{"key":"B19","unstructured":"Norma estatal 2012. Notas Metodol\u00f3gicasExplotaci\u00f3n estad\u00edstica del Conjunto M\u00ednimo B\u00e1sico de Datos Hospitalarios.2012"},{"key":"B20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1469-0691.2004.00921.x","article-title":"Epidemiology of Pneumocystis carinii pneumonia in southern Spain","volume":"10","author":"Calder\u00f3n","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e681","DOI":"10.1097\/MD.0000000000000681","article-title":"Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literature","volume":"94","author":"L\u00f3pez-S\u00e1nchez","year":"2015","journal-title":"Medicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3201\/eid2009.131668","article-title":"Pneumocystis jirovecii pneumonia in patients with or without AIDS, France","volume":"20","author":"Roux","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"B23","volume-title":"Clinical and epidemiological characteristics of Pneumocystis pneumonia in patients without HIV infection in Spain in the period 2003-2007","author":"Garc\u00eda-L\u00f3pez","year":"2014"},{"key":"B24","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/cc6806","article-title":"Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection","volume":"12","author":"Monnet","year":"2008","journal-title":"Crit Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10096-002-0758-5","article-title":"Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients","volume":"21","author":"Roblot","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"CD005590","DOI":"10.1002\/14651858.CD005590.pub3","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","volume":"10","author":"Green","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0176881","DOI":"10.1371\/journal.pone.0176881","article-title":"Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: a retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients","volume":"12","author":"Ricciardi","year":"2017","journal-title":"PLoS ONE"},{"key":"B29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(96)91468-3","article-title":"Pneumocystis carinii infection in patients with chronic bronchial disease","volume":"347","author":"Calderon","year":"1996","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s100960000329","article-title":"Detection of Pneumocystis carinii DNA in patients with chronic lung diseases","volume":"19","author":"Probst","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1051\/parasite\/2011182121","article-title":"Pneumocystis jirovecii colonization in chronic pulmonary disease","volume":"18","author":"Guti\u00e9rrez","year":"2011","journal-title":"Parasite"},{"key":"B32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3201\/eid1102.040487","article-title":"Pneumocystis jirovecii in general population","volume":"11","author":"Medrano","year":"2005","journal-title":"Emerg Infect Dis"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2019.00275\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T12:46:54Z","timestamp":1570193214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2019.00275\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":32,"alternative-id":["10.3389\/fpubh.2019.00275"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2019.00275","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,4]]},"article-number":"275"}}